Stay updated on Pembrolizumab Amurubicin Combo in Refractory SCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Amurubicin Combo in Refractory SCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Amurubicin Combo in Refractory SCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study content and preventing access to the study details.
    Difference
    17%
    Check dated 2026-09-22T22:22:03.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The revision indicator updated from v3.6.6 to v3.7.0, signaling a new site build with behind-the-scenes updates and bug fixes rather than changes to study data.
    Difference
    0.1%
    Check dated 2026-09-15T20:45:48.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page's footer revision was updated from v3.6.5 to v3.6.6, representing a maintenance/template update. It does not change the study content or how users interact with the page.
    Difference
    0.1%
    Check dated 2026-09-01T19:15:53.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.4 to v3.6.5, indicating a new release of the page template. This is a technical update with no indicated changes to study details or visible content.
    Difference
    0.1%
    Check dated 2026-08-11T20:17:36.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The page revision changed from v3.6.3 to v3.6.4, reflecting a minor backend/update with no visible changes to study content or layout.
    Difference
    0.1%
    Check dated 2026-07-28T14:59:57.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    The page now displays a new site revision label, Revision: v3.6.3, replacing the previous Revision: v3.6.0. This indicates a software update to the site rather than changes to the clinical study information shown on the page.
    Difference
    0.1%
    Check dated 2026-06-30T06:50:38.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Amurubicin Combo in Refractory SCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Amurubicin Combo in Refractory SCLC Clinical Trial page.